Contribution of ParE mutation and efflux to ciprofloxacin resistance in Pseudomonas aeruginosa clinical isolates.
Réjiba
S
S
Université Tunis El-Manar, Faculté des Sciences de Tunis, 2092 El-Manar II, Département des Sciences Biologiques, Tunis Tunisia. samia_biochimie@yahoo.fr
Aubry
A
A
Petitfrère
S
S
Jarlier
V
V
Cambau
E
E
D000890:Anti-Infective Agents / Q000494:pharmacology*; D002939:Ciprofloxacin / Q000494:pharmacology*; D027081:DNA Gyrase / Q000235:genetics; D027101:DNA Topoisomerase IV / Q000235:genetics*; D024881:Drug Resistance, Bacterial / Q000235:genetics*; D006801:Humans; D008826:Microbial Sensitivity Tests; D009154:Mutation; D011552:Pseudomonas Infections / Q000188:drug therapy / Q000235:genetics*; D011550:Pseudomonas aeruginosa
D000890:Anti-Infective Agents; D002939:Ciprofloxacin; D027101:DNA Topoisomerase IV; D027081:DNA Gyrase